As promised, this PHN is spreading almost $1.5m around innovators to improve access to primary care.
As promised, this PHN is spreading almost $1.5m around innovators to improve access to primary care.
End of content
No more pages to load
From The Source
- How invisible medical groups are powering telehealth’s GLP-1 ‘gold rush’
- Orthocell quarterly report
- Australian Government response to the Mental Health and Suicide Prevention – Final Report
- Australian Government response to the Inquiry into childhood rheumatic diseases – Interim Report
- 2024 Victorian Honour Roll of Women inductees announced
- Union calls for penalties for workers to be scrapped from Aged Care Act – Health Services Union
- VAHI: MH and AoD treatment services in Victoria
- DoHAC: Restrictive practices in aged care – a last resort
- Nyrada gears up for Phase I clinical trials
- Rats – and investors – are happy as Nyrada forges ahead with its first human trial
- Radiopharm Theranostics (ASX:RAD): Fireside Chat with CEO Riccardo Canevari
- Neuren Pharmaceuticals: DAYBUE™ (trofinetide) receives marketing authorization in Canada